The authors developed a regenerative immunotherapy from the helminth Schistosoma mansoni soluble egg antigen to stimulate production of interleukin-4 and other type 2-associated cytokines, without negative infection-related sequelae.
[Proceedings Of The National Academy Of Sciences Of The United States Of America]
